The Medical Research Council (MRC) has led the development of the UK DRI since November 2015 with a £190 million commitment and operations support. The charities Alzheimer’s Society and Alzheimer’s Research UK joined as founding partners in early 2016, each contributing a further £50 million to the institute.
The UK DRI is a joint £290 million investment into dementia research from three founding funders.
The Medical Research Council is at the forefront of scientific discovery to improve human health. Founded in 1913 to tackle tuberculosis, the MRC now invests taxpayers’ money in some of the best medical research in the world across every area of health. Thirty-one MRC-funded researchers have won Nobel prizes in a wide range of disciplines, and MRC scientists have been behind such diverse discoveries as vitamins, the structure of DNA and the link between smoking and cancer, as well as achievements such as pioneering the use of randomised controlled trials, the invention of MRI scanning, and the development of a group of antibodies used in the making of some of the most successful drugs ever developed. Today, MRC-funded scientists tackle some of the greatest health problems facing humanity in the 21st century, from the rising tide of chronic diseases associated with ageing to the threats posed by rapidly mutating micro-organisms. The MRC is now part of UK Research and Innovation (UKRI).
Alzheimer’s Society is the UK’s leading support and research charity for people with dementia, their families and carers. Dementia affects over 850,000 people in the UK. The Society provides information and support to people with any form of dementia and their carers through our publications, National Dementia Helpline, website and around 3,000 local services throughout England, Wales and Northern Ireland. Alzheimer’s Society supports health and social care professionals by delivering high quality education, resources and training. They influence politicians and policy-makers, and campaign for better quality of life for people living with dementia and their carers and greater understanding of dementia. The Society also funds innovative research in the areas of cause, cure, care and prevention. They work with scientists and people affected by dementia to ensure that the medical and social research programmes we fund have a positive impact on people’s lives.
Alzheimer’s Research UK is the UK’s leading research charity aiming to defeat dementia. The charity’s vision is a world where people are free from the fear, harm and heartbreak of dementia. They power world class studies that give the best chance of beating dementia sooner. Alzheimer’s Research UK funds world-leading research into dementia across the UK and beyond, with a Research Network of over 1,000 scientists, and key research initiatives aimed at delivering new treatments, preventions and improved diagnosis. They provide trusted information about dementia to people affected and their families, helping improve understanding around the condition and the potential for research to defeat it. Alzheimer’s Research UK campaigns to keep dementia research on the political agenda, working to ensure government funding for research is a priority and that the environment is right for biomedical research into dementia to succeed. The charity is building a social movement behind the cause, connecting with thousands of people who are helping to power the fightback against dementia.